Hp. Schlemmer et al., Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy, AM J NEUROR, 22(7), 2001, pp. 1316-1324
Citations number
34
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Neurosciences & Behavoir
BACKGROUND AND PURPOSE: The radiologic assessment of suspicious brain lesio
ns after stereotactic radiotherapy of brain tumors is difficult. The purpos
e of our study was to define parameters from single-voxel proton MR spectro
scopy that provide a probability measure for differentiating neoplastic fro
m radiation-induced, nonneoplastic lesions.
METHODS: Seventy-two lesions in 56 patients were examined using a combined
MR imaging and MR spectroscopy protocol (point-resolved spectroscopy, TE =
135 ms). Signal intensities of cholines, creatines, N-acetyl aspartate, and
the presence of lactate and lipid resonances were correlated to final diag
noses established by clinical and MR imaging follow-up, positron emission t
omography studies, or biopsy/surgery. Statistical analysis was performed us
ing the t test, linear discriminant analysis, and k nearest-neighbor method
.
RESULTS: Significantly increased signal intensity ratios I-tCho/I-tCr (P <
.0001) and I-tCho/I-NAA (P < .0001) were observed in neoplastic (n = 34) co
mpared with nonneoplastic lesions (n = 32) and contralateral normal brain (
n = 33). Analysis Of I-tcho/I-tCr and I-tCho/I-NAA data yielded correct ret
rospective classification as neoplastic and nonneoplastic in 82% and 81% of
the lesions, respectively. Neither I-NAA/I-tCr nor signal intensitities of
lactate or lipids were useful for differential diagnosis.
CONCLUSION. Metabolic information provided by proton MR spectroscopy is use
ful for the differentiation of neoplastic and nonneoplastic brain lesions a
fter stereotactic radiotherapy of brain tumors.